Ginkgo Bioworks DNA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's financing cash flow?
- Ginkgo Bioworks (DNA) reported financing cash flow of -$19K in Q1 2026.
- How has Ginkgo Bioworks's financing cash flow changed year-over-year?
- Ginkgo Bioworks's financing cash flow increased by 90.8% year-over-year, from -$207K to -$19K.
- What is the long-term trend for Ginkgo Bioworks's financing cash flow?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's financing cash flow has grown at a -67.3% compound annual growth rate (CAGR), from $1.55B to $17.78M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.